Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)
NCT01005056 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3838
Last updated 2022-02-04
Summary
The purpose of this study is to evaluate the efficacy and safety of Marvelon® in the prevention of pregnancy.
Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
Conditions
- Contraception
Interventions
- DRUG
-
Ethinylestradiol + Desogestrel
All participants receive Marvelon® according to the approved dosage and administration method.
Sponsors & Collaborators
-
Organon and Co
lead INDUSTRY
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
More Related Trials
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
NCT06394999 ·Status: RECRUITING ·Phase: PHASE3
-
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01252186 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
NCT00185419 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects
NCT03662516 ·Status: COMPLETED ·Phase: PHASE1
-
A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
NCT03608241 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00477633 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CDB-2914 for Emergency Contraception
NCT00411684 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
NCT00551616 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB
NCT02103764 ·Status: UNKNOWN ·Phase: PHASE3
-
Mirena Post-marketing Surveillance in Japan
NCT01414140 ·Status: COMPLETED
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
New Treatments for Troublesome Bleeding in Implanon Users
NCT01384331 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase II Study of Ovulation in Obese Women
NCT06306131 ·Status: RECRUITING ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects
NCT05677035 ·Status: COMPLETED ·Phase: PHASE1
-
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study Into the Contraceptive Effect of Estetrol
NCT00563472 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women
NCT01107106 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
NCT00996580 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
NCT01461824 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
NCT00236769 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
NCT02475356 ·Status: COMPLETED
-
CP-690,550 And Oral Contraception Drug-Drug Interaction Study
NCT01137708 ·Status: COMPLETED ·Phase: PHASE1
-
Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2
NCT01221831 ·Status: COMPLETED ·Phase: PHASE2
-
Drospirenone-only Pill as Emergency Contraception
NCT05675644 ·Status: UNKNOWN ·Phase: PHASE2